Efficacy of Intra-Articular Corticosteroid Injections on Clinical Outcomes in Patients With Operative Distal Radius Fractures
Launched by TEERADON WAEWWORAWIT · May 6, 2024
Trial Information
Current as of September 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of corticosteroid injections on patients with wrist fractures, specifically those who have undergone surgery to fix their injuries. The researchers want to find out if these steroid injections can help improve recovery and overall function compared to a placebo injection, which does not contain the active medication. Participants will be randomly assigned to receive either the steroid injection or the placebo to see which treatment leads to better outcomes.
To be eligible for this trial, participants must be at least 18 years old and have a specific type of wrist fracture that requires surgical treatment. However, people with certain conditions, like allergies to corticosteroids or poorly controlled diabetes, won't be able to join the study. If you decide to participate, you can expect to undergo surgery and receive either the steroid or the placebo injection. Throughout the study, you'll need to complete some questionnaires to help the researchers understand how well the treatments are working. The trial is not yet recruiting participants, but it aims to gather important information to improve treatment for wrist fractures in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age more than 18 years old
- • 2. Closed unstable distal radius fracture unstable type which need surgical management
- • 3. Received procedure ORIF with plate and screws at injured wrist
- Exclusion Criteria:
- • 1. History of corticosteroid allergy
- • 2. Poor Diabetes controlled (HbA1C) \> 8
- • 3. Who need Ritonavir while enter this study
- • 4. Unable to follow up until the end of projects
- • 5. Unable to do questionnaires
- • 6. Infection around injured wrist
- • 7. Tear tendon at injured wrist
- • 8. Open fracture of injured wrist
About Teeradon Waewworawit
Teeradon Waewworawit is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through rigorous scientific investigation. With a focus on innovative therapies and treatment modalities, the organization collaborates with leading researchers and healthcare professionals to design and implement high-quality clinical trials. Teeradon Waewworawit emphasizes ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing to the broader medical community's understanding of various health conditions. Through its commitment to excellence and integrity, the organization aims to drive meaningful advancements in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported